Sunday, November 22, 2026
Home Blog Page 23

Drone hits US-owned gas tanker at Egypt’s Damietta port; no casualties reported

0

A drone hit a US-owned gas storage tanker at Egypt’s Mediterranean port of Damietta, setting off a fire that spread to a second vessel, Reuters reported.The drone struck the Energos Winter, a floating storage and regasification unit owned by US-based Energos Infrastructure. The blaze then spread to the Greek-owned GasLog Salem.

Egypt’s petroleum ministry confirmed fires aboard a gasification vessel and a storage vessel but did not say they were caused by a drone. It said emergency teams brought the fires under control and reported no deaths or injuries.


The crews were evacuated and no damage to the port’s infrastructure was reported.However, it is still unclear who carried out the attack as no group has claimed responsibility yet.

Separately, Tehran and Washington traded attacks, with CENTCOM confirming the conclusion of dozens of strikes against the IRGC. It was done in response to Iran’s missile attacks on US military centre and bases in Jordan.

Source link

Tata Chemicals Q1 in red as weak soda ash pricing, lower realisations pressure profit

0

The world’s second-largest soda ash manufacturer, Tata Chemicals Ltd, on Monday (July 27) reported a consolidated net loss of ₹17 crore for the first quarter ended June 30, 2026, against a net profit of ₹252 crore in the corresponding period last year, primarily due to lower realisations, reduced other income and lower joint venture income.The company’s consolidated revenue from operations rose 14.4% year-on-year to ₹4,255 crore from ₹3,719 crore in the year-ago quarter, driven by higher volumes, which offset lower realisations.

The consolidated Earnings before interest, tax, depreciation and amortisation (EBITDA) declined 14.5% to ₹555 crore during the quarter compared with ₹649 crore in the same period last year. The decline was primarily due to lower realisations in overseas subsidiaries, particularly US exports to Southeast Asia markets.

ALSO READ | Tata Chemicals shares in focus after Q4 hit by impairment, weak soda ash realisationsThe consolidated EBITDA margin stood at 13% in the June quarter, down from 17.5% a year earlier.

The company’s net debt, excluding leases, stood at ₹5,692 crore as of June 30, 2026. Tata Chemicals said net debt declined compared with the previous quarter due to monetisation of assets.

On a standalone basis, Tata Chemicals reported revenue from operations of ₹1,281 crore in Q1FY27, up 10% compared with Q1FY26, driven by higher volumes and realisation.

Standalone EBITDA stood at ₹364 crore, registering a 35% year-on-year growth, supported by higher volumes and realisations, partially offset by an increase in costs. Profit after tax (PAT) from continuing operations stood at ₹343 crore, up 12% compared with Q1FY26.

ALSO READ | Explained — Why Tata Chemicals shares surged as much as 11% in a weak market

R Mukundan, Managing Director & CEO, Tata Chemicals Limited, said, “During Q1FY27, amidst a challenging external environment, the company delivered a resilient performance, supported by higher sales and production volumes, strong operating efficiencies and disciplined cost management. However, exports from the USA to Southeast Asia remained under pressure due to persistent unremunerative soda ash pricing.

Financial results of the Company are aligned with the LIFE (Living, Industrial, Farm Essentials) strategy, reshaping portfolio towards sustainability-led, application-focused businesses while maintaining strength in core capabilities. Thus, transitioning the portfolio to non-cyclical segments, with focused capital allocation to build a structurally resilient growth platform with stable earnings.”

Mukundan said the outlook for the Living Essentials segment remains positive, supported by premiumisation in food, feed, pharma and beverages. Core products such as salt and bicarbonates are expected to deliver stable growth, while prebiotics are likely to grow faster due to rising health and wellness consumption trends.

ALSO READ | Tata Chemicals Q2 profit falls 60% to ₹77 crore on lower realisations, UK reconfiguration

For Industrial Essentials, mainly soda ash, Mukundan said the near-term outlook remains challenging due to global oversupply, weak demand conditions and excess industry capacity. He added that geopolitical tensions and elevated energy, raw material and freight costs continue to put pressure on margins and realisations.

On Farm Essentials, mainly Rallis, Mukundan said India’s farm sector outlook remains moderately positive, supported by improved irrigation, technology adoption, government initiatives and resilient rural demand. However, he noted that monsoon variability, potential El Niño conditions and higher input costs remain key risks to agricultural output.

Shares of Tata Chemicals Ltd ended at ₹698.60, up by ₹14.10, or 2.06%, on the BSE.

ALSO READ | Tata Chemicals arm to buy 100% stake in Singapore-based Novabay for €25 million

Source link

ITR due date extension 2026 LIVE: Who must file tax return even if their income is not taxable?

0

आईटीआर-1 और आईटीआर-2 दाखिल करने वाले करदाताओं के पास अपना आयकर रिटर्न (आईटीआर) दाखिल करने के लिए सिर्फ दो दिन हैं, क्योंकि 31 जुलाई की समय सीमा करीब आ रही है। अब तक लगभग 5 करोड़ रिटर्न दाखिल किए जा चुके हैं, जो दर्शाता है कि करदाता अब अपनी फाइलिंग पूरी करने और जुर्माने, ब्याज और अनुपालन नोटिस से बचने के लिए दौड़ रहे हैं।

कल की नियत तारीख केवल उन निवासी व्यक्तियों पर लागू होती है जिन्हें ऑडिट से गुजरने की आवश्यकता नहीं है। ऐसे करदाताओं में अधिकांश वेतनभोगी कर्मचारी, पेंशनभोगी और छात्र शामिल हैं, जिनकी आय एकाधिक गृह संपत्तियों, ब्याज, लाभांश, पूंजीगत लाभ या अन्य स्रोतों से होती है।

अपना आईटीआर ऑनलाइन कैसे दाखिल करें?

एक करदाता अपने पैन को उपयोगकर्ता आईडी और अपने पासवर्ड के रूप में उपयोग करके लॉग इन करके आयकर विभाग के ई-फाइलिंग पोर्टल पर अपना रिटर्न दाखिल कर सकता है।

कई फिनटेक प्लेटफॉर्म भी लागत पर आईटीआर सेवाएं प्रदान करते हैं, जो अक्सर विशेषज्ञ सहायता, कर-बचत सुझाव और पहले से भरे कर विवरण के साथ आते हैं।

कल आईटीआर किसे दाखिल नहीं करना पड़ेगा?

हालाँकि, प्रत्येक करदाता को 31 जुलाई तक अपना ITR दाखिल करना आवश्यक नहीं है। व्यवसायिक या पेशेवर आय वाले लोग ITR-3 दाखिल करते हैं, साथ ही जो ITR-4 (सुगम) के तहत अनुमानित कराधान योजना का विकल्प चुनते हैं, उनके लिए बाद की तारीख है। यहां बताया गया है कि ऐसे करदाताओं को अपना रिटर्न कब दाखिल करना होगा:

  • 31 अगस्त, 2026: फ्रीलांस से वेतन या व्यावसायिक आय जिसके लिए टैक्स ऑडिट की आवश्यकता नहीं है।
  • 31 अक्टूबर, 2026: व्यावसायिक या व्यावसायिक आय के लिए टैक्स ऑडिट की आवश्यकता है।

अगर आपकी आय पर टैक्स नहीं लगता है तो भी क्या आपको अभी भी आईटीआर दाखिल करने की जरूरत है?

हां, अनिवार्य आईटीआर दाखिल करने का एक सबसे बड़ा कारण यह है कि जब आपकी कुल आय मूल छूट सीमा से अधिक हो जाती है, जिसका अर्थ है कि इस सीमा से नीचे की कोई भी आय अन्य निर्धारित शर्तों को पूरा करने पर आईटीआर दाखिल करना छोड़ सकती है।

पुरानी कर व्यवस्था के तहत छूट की सीमा है ₹60 वर्ष से कम आयु के व्यक्तियों के लिए 2.5 लाख, ₹वरिष्ठ नागरिकों के लिए 3 लाख (60 वर्ष लेकिन 80 वर्ष से कम आयु) और ₹अति वरिष्ठ नागरिकों (80 वर्ष या अधिक) के लिए 5 लाख। इस बीच नई कर व्यवस्था के अनुसार, मूल छूट सीमा है ₹सभी आयु वर्ग के करदाताओं के लिए 4 लाख।

यहां कुछ कारण दिए गए हैं जो आईटीआर दाखिल करना अनिवार्य बनाते हैं:

  • बचत बैंक जमा से अधिक ₹50 लाख
  • चालू खाता जमा पार ₹1 करोड़
  • विदेश यात्रा पर खर्च अधिक होता है ₹2 लाख
  • बिजली का बिल ज्यादा आता है ₹1 लाख
  • आपके पास विदेशी संपत्ति है या आपके पास विदेश में हस्ताक्षर करने का अधिकार है

यह लाइव ब्लॉग नवीनतम अपडेट को ट्रैक करेगा कि किसे 31 जुलाई तक फाइल करना होगा, किसे अतिरिक्त समय मिलेगा, समय सीमा चूकने पर जुर्माना, महत्वपूर्ण आईटीआर फॉर्म, पोर्टल विकास दाखिल करना और अंतिम समय के करदाताओं के लिए विशेषज्ञ मार्गदर्शन।

Source link

US-Iran War Live Updates: US sanctions two more firms tied to Iran’s Hormuz payment scheme

0

US-Iran War Live Updates: Trump vowed to “hit them very hard” after accusing Iran of launching another overnight missile attack, while a drone struck a US-owned tanker off Egypt in an incident whose perpetrator remains unclear. Adding to concerns over global oil trade, Yemen’s Houthis are weighing fees on commercial ships transiting the Red Sea. Follow for latest updates.

Source link

India says US trade deal will start once it gets an edge over rival exporters

0

Commerce and Industry Minister Piyush Goyal said India expects the first tranche of its Bilateral Trade Agreement (BTA) with the United States to come into force once Washington ensures India enjoys a tariff advantage over competing exporters in neighbouring countries and the ASEAN region.Speaking on Thursday, Goyal said India would continue to leverage opportunities in the US market “as long as we have a comparative advantage on comparable duties.” India and the US had announced the proposed BTA in a joint statement on February 7, 2026.On investigations launched by the US Trade Representative (USTR) under Section 301 of the US Trade Act, Goyal said India had participated in the proceedings. He noted that the US has already imposed a 10% tariff following its probe into forced labour, while another investigation into excess capacity is underway.Asked about reports that the US could impose tariffs on imports linked to Russian oil, Goyal declined to comment, describing the matter as speculative.The minister also said the legal review of the India-European Union free trade agreement is nearing completion. Once finalised, the agreement will be sent to the European Parliament and other relevant institutions within the 27-member bloc for approval.Following a meeting with Export Promotion Councils, Goyal said exporters were optimistic about India’s free trade agreements with Oman and the UK, which provide zero-duty access for Indian exports to both markets.

Source link

Senores Pharma Q1 Results: Regulated markets power 56% profit growth, margin expansion

0

Senores Pharmaceuticals reported a strong set of June-quarter earnings on Monday, driven by robust growth in its regulated markets business, higher operating margins and continued expansion of its product portfolio, reinforcing management’s confidence in sustaining growth through FY27.The pharmaceutical company posted a 56% year-on-year rise in net profit to ₹31 crore, while revenue increased 36% to ₹180 crore. EBITDA surged 87% to ₹54 crore, with EBITDA margin expanding sharply to 30% from 22% a year earlier.

Following the earnings announcement, shares of Senores Pharmaceuticals Ltd climbed to an intraday high of ₹1,443.70 before trimming gains. The stock was trading at ₹1,411.50, up 1.83%, in afternoon trade.

Regulated markets remain the key growth engineThe company’s regulated markets business continued to lead growth during the quarter, with revenue from the segment rising 42% year-on-year.

Management attributed the performance to continued portfolio expansion and differentiated sales and distribution channels. Senores nearly doubled its approved ANDA portfolio over the past year, increasing it from 30 approved ANDAs in June 2025 to 58 approvals by June 2026, of which 23 products have already been commercialised.

The company said it has adopted a balanced strategy of combining in-house product development with targeted acquisitions to strengthen its presence in regulated markets.

Meanwhile, the emerging markets business also maintained healthy momentum, recording around 30% year-on-year revenue growth during the quarter. The segment delivered an EBITDA margin of approximately 14%, supported by a greater focus on niche products and streamlined go-to-market strategies. Management added that the emerging markets business has now turned cash-flow positive.

Expansion plans underpin FY27 outlook

Senores also highlighted the strategic importance of its recently added USFDA-approved manufacturing facility in Baroda, which is expected to improve scalability and support faster product launches in regulated markets.

The facility is also expected to enhance operating leverage, strengthen margins and create additional opportunities in the contract development and manufacturing (CDMO) and contract manufacturing (CMO) businesses. Production has already been ramped up at the Apnar facility, with full-scale expansion expected over the next 12 to 18 months.

Managing Director Swapnil Shah said the company delivered healthy growth despite a challenging operating environment, supported by clearly defined strategic priorities and continued execution across key markets.

Looking ahead, Senores maintained an optimistic outlook for FY27, citing a differentiated product portfolio, a strong pipeline of commercial launches and improved execution visibility. Management said it expects strong revenue growth and expanding profitability over the remainder of the financial year, underpinned by continued portfolio additions and increasing scale in both regulated and emerging markets.

Source link

Japan’s Nikkei rises on sharp Advantest gains

0

Japan’s Nikkei share average rose on Thursday, driven by sharp gains in Advantest after the chip-testing equipment maker raised its annual profit forecast, while banks ‌dragged ⁠the broader ⁠Topix lower. The Nikkei was up 0.81% at 61,934.03 as of 0050 GMT, while the Topix fell 0.81% to 3,941.8.

Advantest jumped 10% after raising its annual operating profit forecast by 35% ⁠on Wednesday ‌as AI spending drives demand for its chip-testing equipment.

“Thanks to Advantest’s ⁠tremendous outlook, shares in other chip-related stocks rose,” said Kazuaki Shimada, chief strategist at IwaiCosmo Securities.

Chip-making equipment maker Tokyo Electron rose 4.3%. Memory maker Kioxia jumped 11%.


Mitsubishi UFJ Financial Group and Sumitomo Mitsui Financial Group ‌lost 2.58% and 1.8%, respectively.
“This is a typical trend in recent sessions where ⁠AI-related shares are strong, value shares such as banks are sold off,” said Shimada. Of the more than 1,500 stocks trading on the Tokyo Stock Exchange’s prime market, 14% rose, 84% fell and 1% traded flat.

Source link

Stock market rally explained: What lifted Sensex by 776 points today?

0

The equity benchmark indices kicked off the week on a strong note on Monday (July 27), with the BSE Sensex rising 776 points to close at 76,836, while the Nifty 50 gained 229 points to end at 23,996, reclaiming the 24,000 level during the session.The rally was broad-based, with market breadth firmly favouring advances. The advance-decline ratio stood at 2:1, indicating that gainers significantly outnumbered losers.

The Nifty Bank index climbed 394 points to 57,087, while the Nifty Midcap Index advanced 681 points to 62,304.

Here are the key reasons behind today’s rally:1. Financial stocks lead gainsFinancial stocks, particularly non-banking financial companies (NBFCs), witnessed strong buying, tracking movements in the rupee and crude oil prices.

ALSO READ | Tata Consumer shares jump nearly 3% after strong India business in Q1; analysts retain ‘buy’

2. Auto shares gain as crude falls

Automobile stocks attracted buying interest after crude oil prices declined 10% from Friday’s levels, supporting sentiment across the sector.

3. Crude-linked sectors outperform

Crude derivatives-related stocks saw significant movement. Oil marketing companies (OMCs) and airline stocks advanced, while upstream oil companies slipped.

4. Company-specific triggers support the rally

KFin Technologies surged more than 10% following positive commentary for FY27. Container Corporation of India (CONCOR) gained 7% after doubling its volume guidance for FY27.

ALSO READ | Laurus Labs shares hit record high after multiple upgrades, but Kotak still sees 33% downside

IDFC First Bank, AU Small Finance Bank and Lodha rose 5-6% after reacting positively to their first-quarter results. Information technology stocks extended Friday’s gains, with Oracle Financial Services Software (OFSS) rising 4% and Coforge gaining 2% ahead of its earnings announcement.

5. Mixed moves in select stocks

Exide Industries and Nuvama Wealth Management declined as both stocks will exit the futures and options (F&O) segment from Wednesday. Bank of India was among the top midcap losers after reporting in-line first-quarter results. CarTrade Tech extended its rally, gaining another 12% following a positive brokerage note.

From the Sensex basket, Eternal Ltd, InterGlobe Aviation Ltd, Infosys Ltd, Bajaj Finance Ltd, Max Healthcare Institute Ltd and Asian Paints Ltd were the major gainers. Oil and Natural Gas Corporation Ltd, HDFC Bank Ltd, Cipla Ltd and Axis Bank Ltd were the biggest laggards.

Gurmeet Chadha, Managing Partner & CIO, Complete Circle, On Eternal, said, “We continue to add Eternal in our portfolios. If you see the Q1 numbers, the net working capital days were down from 18 days to 14 days, which is phenomenal, considering that they are expanding dark stores.

ALSO READ | Tamilnad Mercantile Bank Q1 Results: Stock at record high after 11% jump on strong earnings

And I think the market share, once somebody crosses 50%, the unit economics change considerably. Although their AOV dropped to ₹506-508, the frequency of orders went up. I think the unit economics stand out. I was very impressed by the presentation and disclosures. I mean, for any young investor tracking new-age businesses, I think it’s a perfect time to look at the earnings snippets, thanks to digital media.

Swiggy and Zepto are also struggling with Amazon Now. And typically, what happens is, in this environment, which we have seen earlier, a new entrant tends to take market share from the other ones rather than the dominant player. Also, there’s a pushback. So, in the unlisted market, Zepto was about ₹38-39.

The price as of Friday—I have not checked today—is more like ₹33-34. So, it’s a bit of a pushback on valuation. The grey market prices are there, and I think now, in this kind of environment, you want more visibility in terms of when the cash burn will reduce, etc. So, we continue to be overweight on Eternal here. Other than that, we don’t have anything in quick commerce.”

Source link

Indo-MIM IPO listing date today. GMP, analysts signal share debut at a strong premium on BSE, NSE

0

इंडो-एमआईएम आईपीओ लिस्टिंग: आरंभिक सार्वजनिक पेशकश (आईपीओ) को निवेशकों से मजबूत मांग मिलने के बाद इंडो-एमआईएम के शेयर आज भारतीय शेयर बाजार में सूचीबद्ध होने के लिए तैयार हैं। इंडो-एमआईएम आईपीओ लिस्टिंग की तारीख 30 जुलाई 2026, गुरुवार है।

इंडो-एमआईएम आईपीओ 23 जुलाई से 27 जुलाई तक सदस्यता के लिए खुला था, जबकि इंडो-एमआईएम आईपीओ आवंटन स्थिति को 28 जुलाई को अंतिम रूप दिया गया था। इंडो-एमआईएम आईपीओ लिस्टिंग की तारीख 30 जुलाई है, और स्टॉक दोनों स्टॉक एक्सचेंजों, बीएसई और एनएसई पर सूचीबद्ध किया जाएगा।

बीएसई पर एक नोटिस में कहा गया है, “एक्सचेंज के ट्रेडिंग सदस्यों को सूचित किया जाता है कि गुरुवार, 30 जुलाई, 2026 से प्रभावी, INDOMIM लिमिटेड के इक्विटी शेयरों को ‘बी’ ग्रुप ऑफ सिक्योरिटीज की सूची में एक्सचेंज पर सूचीबद्ध किया जाएगा और लेनदेन के लिए स्वीकार किया जाएगा।”

इसके अलावा, ट्रेडिंग सदस्य कृपया ध्यान दें कि उपर्युक्त शेयर गुरुवार, 30 जुलाई, 2026 को विशेष प्री-ओपन सत्र (एसपीओएस) का हिस्सा होगा, और शेयर सुबह 10:00 बजे से ट्रेडिंग के लिए उपलब्ध होंगे।

आज इंडो-एमआईएम आईपीओ लिस्टिंग से पहले, निवेशक अनुमानित लिस्टिंग मूल्य का अनुमान लगाने के लिए ग्रे मार्केट प्रीमियम (जीएमपी) के रुझान पर नजर रखते हैं। इंडो-एमआईएम आईपीओ जीएमपी आज और विश्लेषकों ने शेयरों की मजबूत शुरुआत का संकेत दिया है।

यह भी पढ़ें | इंडो-एमआईएम बनाम एक्स्ट्रानेट बनाम लोहिया कॉर्प आईपीओ: लिस्टिंग के लिए जीएमपी क्या संकेत देता है?

इंडो-एमआईएम आईपीओ जीएमपी आज शेयर लिस्टिंग के बारे में क्या संकेत देता है:

इंडो-एमआईएम आईपीओ जीएमपी आज

ग्रे मार्केट में इंडो-एमआईएम के शेयरों में जोरदार प्रीमियम देखने को मिल रहा है। गैर-सूचीबद्ध बाजार पर नज़र रखने वाली वेबसाइटों के अनुसार, इंडो-एमआईएम आईपीओ जीएमपी आज है ₹186 प्रति शेयर। इससे पता चलता है कि ग्रे मार्केट में इंडो-एमआईएम के शेयर ऊंचे स्तर पर कारोबार कर रहे हैं ₹उनके आईपीओ मूल्य से 186 प्रति शेयर।

इंडो-एमआईएम आईपीओ लिस्टिंग मूल्य

आज इंडो-एमआईएम आईपीओ जीएमपी को ध्यान में रखते हुए स्टॉक की अनुमानित लिस्टिंग कीमत होगी ₹671 प्रत्येक, जो कि निर्गम मूल्य से 38.35% प्रीमियम पर है ₹485 प्रति शेयर।

विश्लेषकों को यह भी उम्मीद है कि इंडो-एमआईएम के शेयर आज भारतीय शेयर बाजार में मजबूत प्रीमियम के साथ सूचीबद्ध होंगे।

“मजबूत बाजार की उम्मीद 38% वास्तविक बुनियादी सिद्धांतों को दर्शाती है, न कि केवल प्रचार – दुनिया का सबसे बड़ा एमआईएम खिलाड़ी, वैश्विक नेतृत्व के लगातार 6 साल, 28% राजस्व वृद्धि + FY26 में 26% PAT वृद्धि, स्वस्थ 21.3% RoNW, और ₹स्वस्तिका इन्वेस्टमार्ट में वेल्थ प्रमुख शिवानी न्याति ने कहा, “400 करोड़ की लिस्टिंग आय ऋण चुकौती (डिलीवरेजिंग, न कि किसी भी कीमत पर कम करने) की ओर जा रही है।”

उनके अनुसार, 45x पी/ई पर, इंडो-एमआईएम शेयर सस्ते नहीं हैं, लेकिन खाई (प्रौद्योगिकी + स्केल + विविध अंत-बाज़ार) उतार-चढ़ाव के बजाय अस्थिरता के माध्यम से पकड़ बनाए रखने का समर्थन करता है।

यह भी पढ़ें | इंडो-एमआईएम आईपीओ आज खुला: समीक्षा के लिए जीएमपी, तारीख, कीमत। आवेदन करें या नहीं?

इंडो-एमआईएम आईपीओ सदस्यता स्थिति, मुख्य विवरण

मेनबोर्ड आईपीओ के लिए बोली 23 जुलाई, गुरुवार को शुरू हुई और 27 जुलाई, सोमवार को समाप्त हुई। इंडो-एमआईएम आईपीओ आईपीओ आवंटन 28 जुलाई, मंगलवार था, और इंडो-एमआईएम आईपीओ लिस्टिंग की तारीख 30 जुलाई, गुरुवार है। इंडो-एमआईएम के शेयर बीएसई और एनएसई पर सूचीबद्ध होंगे।

इंडो-एमआईएम आईपीओ का प्राइस बैंड निर्धारित किया गया था ₹461 से ₹485 प्रति शेयर। कंपनी ने उठाया ₹बुक-बिल्डिंग इश्यू से 3,811.21 करोड़ रुपये, जो 1.03 करोड़ इक्विटी शेयरों के ताजा इश्यू का संयोजन है ₹499.10 करोड़, और कुल मिलाकर 6.83 करोड़ शेयरों की बिक्री का प्रस्ताव (ओएफएस) ₹3,311.21 करोड़।

एनएसई के आंकड़ों से पता चलता है कि इंडो-एमआईएम आईपीओ को कुल 72.34 गुना सब्सक्राइब किया गया था। रिटेल इंडिविजुअल इन्वेस्टर्स (आरआईआई) सेगमेंट को 6.67 गुना बुक किया गया, जबकि गैर-संस्थागत निवेशकों (एनआईआई) हिस्से को 50.63 गुना सब्सक्राइब किया गया। क्वालिफाइड इंस्टीट्यूशनल बायर्स (क्यूआईबी) श्रेणी को 204.34 गुना सब्सक्रिप्शन मिला।

एचडीएफसी बैंक लिमिटेड बुक रनिंग लीड मैनेजर है और एमयूएफजी इनटाइम इंडिया प्राइवेट लिमिटेड है। लिमिटेड इंडो-एमआईएम आईपीओ रजिस्ट्रार है।

यह भी पढ़ें | इंडो-एमआईएम आईपीओ: जीएमपी में उछाल, इश्यू को 72.34 गुना अभिदान मिला

अस्वीकरण: यह कहानी केवल शैक्षिक उद्देश्यों के लिए है। उपरोक्त विचार और सिफारिशें व्यक्तिगत विश्लेषकों या ब्रोकिंग कंपनियों के हैं, मिंट के नहीं। हम निवेशकों को कोई भी निवेश निर्णय लेने से पहले प्रमाणित विशेषज्ञों से जांच करने की सलाह देते हैं।

Source link

US strikes $58.6 billion Patriot missile deal amid rising stockpile concerns

0

The US Army awarded Lockheed Martin a contract worth up to $58.6 billion to produce Patriot interceptor missiles, the Pentagon said on Wednesday, as conflicts in Iran and Ukraine strain US weapons stockpiles.The US has supplied large quantities of ‌weapons to allies while also using munitions in its own military operations in Iran, raising concerns about inventories of key air defense and precision-guided weapons.

The Lockheed award converts a previous one-year deal worth $4.7 billion awarded in April into a seven-year draft agreement, creating a multiyear procurement plan for the interceptors from fiscal 2026 through 2032, the Army said.


Pentagon negotiators ​are pressing contractors to move much faster, with tentative production agreements struck earlier this year at the center of efforts to increase missile output. The administration of President Donald Trump has also steadily increased pressure on defense contractors to prioritize production over shareholder payouts. Trump signed an executive order in January to identify contractors deemed to be underperforming on government contracts while continuing to distribute profits to shareholders.Industry executives have welcomed the production agreements, but said Congress must first appropriate funding before companies can invest more heavily in components and production capacity.

Exact terms and delivery dates for many Pentagon munitions deals are still under negotiation.

A similar framework deal had been struck with Raytheon’s parent company RTX to boost production of Tomahawk cruise missiles from the current rate of about 60 per year for the US to eventually 1,000 units annually.

Lockheed, a Bethesda, Maryland-based defense contractor, said the funding would allow it to follow through on a promise to triple PAC-3 MSE production capacity by the end of 2030 and increase jobs at its Camden, Arkansas, plant by 50%, to about 1,850 from 1,200. Lockheed previously announced Patriot PAC-3 missile interceptor production would go to 2,000 units annually.Lockheed Martin said it is investing $8 billion to $9 billion through 2030 to modernize more than 20 US facilities, including new munitions centers in Alabama and Arkansas.

PAC-3 MSE is a hit-to-kill interceptor used within the Patriot air defense system to counter ballistic missiles, cruise missiles and aircraft.

The Center for Strategic and International Studies, a Washington-based think tank, estimated this week that the US military has fewer than 1,000 Patriot interceptors on hand and fewer than 250 THAAD interceptors — two key air defense systems. Both have seen recent heavy use in the Middle East.

Source link